NASDAQ:ITIC opened at $154.59 on Tuesday. The company has a market capitalization of $292.02 million, a PE ratio of 12.03 and a beta of 0.50. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.03. Investors Title has a 12-month low of $153.01 and a 12-month high of $202.85.
Investors Title (NASDAQ:ITIC) last released its earnings results on Friday, May 3rd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter. The business had revenue of $39.95 million for the quarter. Investors Title had a return on equity of 13.16% and a net margin of 14.99%.
Institutional investors have recently bought and sold shares of the stock. BNP Paribas Arbitrage SA boosted its stake in shares of Investors Title by 722.9% in the first quarter. BNP Paribas Arbitrage SA now owns 288 shares of the insurance provider’s stock valued at $45,000 after buying an additional 253 shares in the last quarter. Secrest Blakey & Associates LLC purchased a new stake in shares of Investors Title in the first quarter valued at approximately $75,000. Metropolitan Life Insurance Co. NY purchased a new stake in shares of Investors Title in the fourth quarter valued at approximately $89,000. SG Americas Securities LLC purchased a new stake in shares of Investors Title in the fourth quarter valued at approximately $110,000. Finally, MetLife Investment Advisors LLC purchased a new stake in shares of Investors Title in the fourth quarter valued at approximately $121,000. Hedge funds and other institutional investors own 42.13% of the company’s stock.
About Investors Title
Investors Title Company, through its subsidiaries, provides title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies.
Featured Story: Return on Investment (ROI)
Receive News & Ratings for Investors Title Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Investors Title and related companies with MarketBeat.com's FREE daily email newsletter.